School of Biomedical Sciences
Menu

Publications

2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2006 |

2012

  1. Ondricek AJ, Kashyap AK, Thamake SI, Vishwanatha JK, A comparative study of phytoestrogen action in mitigating apoptosis induced by oxidative stress, In Vivo. 2012 Sep; 26(5):765-75.
  2. Amalendu P Ranjan, Anindita Mukerjee, Lawrence Helson and Jamboor K Vishwanatha, Scale up, Optimization and Stability Analysis of Curcumin C3 complex-loaded Nanoparticles for Cancer Therapy,  2012, 10:38 doi:10.1186/1477-3155-10-38
  3. Praveenkumar K. Shetty, Sanjay I. Thamake, Swati Biswas, Sonny L. Johansson, Jamboor K. Vishwanatha, Reciprocal regulation of Annexin A2 and EGFR with Her-2 in Her-2 negative and Herceptin-resistant breast cancer, PLOS ONE 7(9): e44299. doi:10.1371/journal.pone.0044299
  4. Thamake SI, Raut SL, Gryczynski Z, Ranjan AP, Vishwanatha JK., Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer. Biomaterials. 2012 Oct;33(29):7164-73. Epub 2012 Jul 12.
  5. Mukerjee A, Ranjan AP, Vishwanatha JK., Combinatorial nanoparticles for cancer diagnosis and therapy. Curr Med Chem. 2012 Aug 1;19(22):3714-21.
  6. Fudala R, Rich R, Mukerjee A, Ranjan AP, Vishwanatha JK, Kurdowska AK, Gryczynski Z, Borejdo J, Gryczynski I., Fluorescence Detection of MMP-9.II. Ratiometric FRET-Based Sensing With Dually Labeled Specific Peptide., Curr Pharm Biotechnol. 2012 Feb 20. [Epub ahead of print]
  7. Dasgupta S, Srinidhi S, Vishwanatha JK., Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges, J Carcinog. 2012;11:4. Epub 2012 Feb 17.

back to top

2011

  1. Valapala, M. and Vishwanatha, J.K.  Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2.  J. Biol. Chem. (Accepted for publication, July 7, 2011).
  2. Dasgupta, S., Cushman, I., Kpetemey, M., Casey, P.J. and Vishwanatha, J.K. Prenylated C17ORF37 induces filopodia formation to promote cell migration and metastasis.  J. Biol. Chem. 2011 Jul 22;286(29):25935-46. Epub 2011 May 31.
  3. Ranjan, A. P., Zeglam, K., Thamake, S.I., Mukerjee, A. and Vishwanatha, J.K. (2011) A sustained release formulation of chitosan modified PLCL: Poloxamer blend nanoparticles loaded with thermo-optical agent for animal imaging.  Nanotechnology 22(29):295104. Epub 2011 Jun 21. PMID: 1693801.
  4. Chiu, S.S., Lui, E., Majeed, M., Vishwanatha, J.K., Ranjan, A.P., Maitra, A., Pramanik, D., Smith, J.A. and Helson, L. (2011)  Differential distribution of intravenous curcumin formulations in the rat brain. Anticancer Res. 31(3): 907-911.  PMID: 21498712.
  5. Cardarelli KM, Jackson RS, Martin M, Linnear K, Lopez R, Senteio C, Weaver P, Hill A, Epperson-Brown M, Parish D, Newton JR, Haley S, Vishwanatha JK, Johnson E. (2011) Community-based participatory approach to reduce breast cancer disparities in South Dallas.  Progress in Community Health Partnerships (Accepted for publication, March 28th, 2011)
  6. Zhang, F.-F., Morabia, A., Carroll, J., Gonzalez, K., Fulda, K., Kaur, M., Vishwanatha, J.K., Santella, R.M. and Cardarelli, R. (2011) Dietary patterns and global genomic DNA methylation in a cancer-free population.  J. Nutr. published 27 April 2011, 10.3945/jn.110.134536. PMID: 21525250.
  7. Valapala, M., Thamake, S.I. and Vishwanatha, J.K. (2011) A competitive hexapeptide inhibitor of Annexin A2 prevents hypoxia-induced angiogenic events.  J. Cell Sci. 124: 1453-1464. PMID: 21486955
  8. Thamake, S.I., Raut, S.L., Ranjan, A.P., Gryczynski, Z. and Vishwanatha, J.K. (2011) Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy.  Nanotechnology 22(3):035101. Epub 2010 Dec 9. PMID: 21149963.
  9. Fudala, R., Ranjan, A.P., Mukerjee, A., Vishwanatha, J.K., Gryczynski, Z., Borejdo, J., Sarkar, P. and  Gryczynski, I. (2011)  Fluorescence Detection of MMP-9. I. MMP-9 Selectively Cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys Peptide.  Curr. Pharm. Biotechnol. 12:834-838. PMID: 21446907.
  10. Raut, S., Heck, A., Vishwanatha, J.K., Sarkar, P., Mody, A., Luchowski, R., Gryczysnki, Z., and Gryczynski, I. (2011) Fluorescent Properties of Antioxidant Cysteine ABZ Analogue.  J. Photochem. Photobiol. B. Biology 102: 241-245. PMID: 21237671
  11. Zhang, F.-F., Cardarelli, R., Carroll, J., Zhang, S., Fulda, K., Gonzalez, K., Vishwanatha, J.K., Morabia, A. and Santella, R.M. (2011)  Physical activity and global genomic DNA methylation in a cancer-free population.  Epigenetics 6(3):293-9.PMID: 21178401
  12. Nejtek, V.A., Kaiser, K., Vo, H., Hilburn, C. Lea, J., and Vishwanatha, J.K. (2011) Are there racial/ethnic differences in indigent inner-city clients with dual diagnoses?  J. Dual Diagnosis 7(1-2): 26-38.\

back to top

2010

  1. Shankardas, J., Patil, R. V. and Vishwanatha, J.K. (2010) Effect of down-regulation of aquaporins in human corneal endothelial and epithelial cell lines.  Mol. Vision 16:1538-1548.  PMID: 20806077 PMCID: PMC2925904
  2. Mukerjee, A., Sørensen, T.J., Ranjan, A.P., Raut, S., Gryczynski, I., Vishwanatha, J.K. and Gryczynski, Z.  (2010) Spectroscopic Properties of Curcumin: Orientation of Transition Moments.  J Phys Chem B. 114(39):12679-84. PMID: 20839868.
  3. Das, S., Shetty, P., Valapala, M., Dasgupta, S., Gryczynski, Z. and Vishwanatha, J.K. (2010) Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells.  Biochemistry,49 (10):2216–2226.  PMID: 20121258.
  4. Cardarelli, R., Cardarelli, K.M., Carroll, J., Fulda, K.G., Espinoza, A., Cage, C., Vishwanatha, J.K., Young, R. and Steele, D. N. (2010) Perceived racial discrimination, response to unfair treatment, and coronary calcification in asymptomatic adults – the North Texas Healthy Heart Study.  BMC Public Health, 10:285. PMID: 20507602.
  5. Mukerjee, A., Luchowski, R., Ranjan, A.P., Raut, S., Vishwanatha, J.K., Gryczynski, Z. and Gryczynski, I. (2010) Enhanced fluorescence of curcumin on plasmonic platforms.  Curr. Phar. Biotech. 11(2):223-228. PMID: 20210735.
  6. Deshmukh, A., Kim, B.-J., Gonzales, X., Caffrey, J., Vishwanatha, J.K. and Jones, H.P. (2010) A murine model of stress-controllability and stress-induced allergic airway hypersensitivity.  J. Neuroimmunol. J. Neuroimmunol. 225:13-21. PMID: 20462642.

back to top

2009

  1. Dasgupta, S., Wasson, L.M., Rauniyar, N., Prokai, L., Borejdo, J. and Vishwanatha, J.K. (2009) Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells.  Oncogene 28(32):2860-72. PMID: 19503095.
  2. Mukerjee, A., and Vishwanatha, J.K. (2009)  Formulation, characterization and evaluation of curcumin loaded PLGA nanospheres for cancer therapy.  Anticancer Res. 29(10):3867-3875. PMID: 19846921.
  3. Carroll, J.F., Fulda, K.G., Chiapa, A.L., Rodriguez, M., Phelps, D.R., Cardarelli, K.M., Vishwanatha, J.K., Cardarelli, R. (2009) Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers. Obesity 17(7):1420-1427. PMID: 19197255.
  4. Braden,A. R., Kafka, M.T., Cunningham, L., Jones, H. and Vishwanatha, J.K. (2009) Polymeric nanoparticles for sustained down-regulation of annexin A2 inhibit prostate tumor growth.  J. Nanosci. Nanotech. 9(5):2856-2865. PMID: 19452941.

2008

  1. Reeves, R.E., Vishwanatha, J.K., Yorio, T., Budd, M., Sheedlo, H.J. (2008) The Post-baccalaureate Premedical Certification Program at the University of North Texas Health Science Center Strengthens Admission Qualifications for Entrance into Medical School. Academic Medicine, 83(1):45-51. PMID: 18162749.
  2. Bhutia, S.K., Mallick, S.K., Stanley, S.M., Prokai, L, Vishwanatha, J.K. and Maiti, T.K. (2008) Induction of mitochondria-dependent apoptosis by Abrus agglutinin-derived peptides in human cervical cancer cell.  Toxicol. In vitro 22(2):344-351.
  3. Carroll J.F., Chiapa A.L., Rodriguez M., Phelps D.R., Cardarelli K.M., Vishwanatha J.K., Bae S., Cardarelli R. (2008) Visceral fat, waist circumference and body mass index: Impact of race/ethnicity. Obesity.  16(3):600-607.
  4. Kafka, E.L., Braden, A. and Vishwanatha, J.K. (2008) Characterization of nanoparticle-mediated drug delivery to NB4: feasibility of nanoparticle use for cells in suspension and blood diseases.  J. Biomed. Nanotechnol. 4, 196–202. PMID: 19452941

back to top

2007

  1. Braden, A., Kashyap, A., Vasir, J., Labhasetwar, V. and Vishwanatha, J.K. (2007) Polymeric nanoparticles for sustained down-regulation of Annexin A2 lead to reduction in proliferation and migration of prostate cancer cells.  J. Biomed. Nanotech. 3(2):148-159.
  2. Das, S., Roth, C.P., Wasson, L.M. and Vishwanatha, J.K. (2007) Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.  Prostate 67:1550-1564.
  3. Liu, J. and Vishwanatha, J.K. (2007) Regulation of nucleo-cytoplasmic shuttling of human annexin II – A proposed mechanism.  Mol. Cell. Biochem. 303:211-220.|
  4. Banerjee, A. G., Gopalakrishnan, V.K. and Vishwanatha, J.K. (2007) Nicotine Inhibits Nitric Oxide-induced Apoptosis in Oral Epithelial Cells. Mol. Cell. Biochem. 305(1-2):113-21.

back to top

2005

  1. Banerjee, A.G., Bhattacharyya, I. and Vishwanatha, J.K. (2005) Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia.  Mol. Cancer Therap. 4(6): 865-875.
  2. Rothermund, C.A., Gopalakrishnan, V.K., Eudy, J.D. and Vishwanatha, J.K. (2005) Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model.  BMC Urology 5: 5.

This page was last modified on September 1, 2023